BASTEI LUBBE AG (BST.DE) Stock Fundamental Analysis

Europe Frankfurt Stock Exchange FRA:BST • DE000A1X3YY0

7.46 EUR
-0.28 (-3.62%)
Last: Feb 6, 2026, 07:00 PM
Fundamental Rating

5

Taking everything into account, BST scores 5 out of 10 in our fundamental rating. BST was compared to 68 industry peers in the Media industry. BST scores excellent on profitability, but there are some minor concerns on its financial health. BST is valued correctly, but it does not seem to be growing. BST also has an excellent dividend rating. These ratings would make BST suitable for dividend investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year BST was profitable.
  • BST had a negative operating cash flow in the past year.
  • In the past 5 years BST has always been profitable.
  • BST had a positive operating cash flow in 4 of the past 5 years.
BST.DE Yearly Net Income VS EBIT VS OCF VS FCFBST.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.78%, BST belongs to the top of the industry, outperforming 92.65% of the companies in the same industry.
  • BST's Return On Equity of 13.88% is fine compared to the rest of the industry. BST outperforms 79.41% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 11.80%, BST belongs to the top of the industry, outperforming 88.24% of the companies in the same industry.
  • BST had an Average Return On Invested Capital over the past 3 years of 11.74%. This is above the industry average of 7.91%.
  • The last Return On Invested Capital (11.80%) for BST is above the 3 year average (11.74%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.78%
ROE 13.88%
ROIC 11.8%
ROA(3y)7.31%
ROA(5y)8.15%
ROE(3y)12.63%
ROE(5y)15.01%
ROIC(3y)11.74%
ROIC(5y)11.8%
BST.DE Yearly ROA, ROE, ROICBST.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • The Profit Margin of BST (8.23%) is better than 82.35% of its industry peers.
  • BST's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 11.41%, BST is in the better half of the industry, outperforming 73.53% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BST has grown nicely.
  • Looking at the Gross Margin, with a value of 51.60%, BST is in line with its industry, outperforming 55.88% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BST has grown nicely.
Industry RankSector Rank
OM 11.41%
PM (TTM) 8.23%
GM 51.6%
OM growth 3Y5.11%
OM growth 5Y25.16%
PM growth 3Y-4.99%
PM growth 5YN/A
GM growth 3Y1.19%
GM growth 5Y3.74%
BST.DE Yearly Profit, Operating, Gross MarginsBST.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BST is still creating some value.
  • BST has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, BST has about the same amount of shares outstanding.
  • Compared to 1 year ago, BST has an improved debt to assets ratio.
BST.DE Yearly Shares OutstandingBST.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
BST.DE Yearly Total Debt VS Total AssetsBST.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

2.2 Solvency

  • BST has an Altman-Z score of 3.02. This indicates that BST is financially healthy and has little risk of bankruptcy at the moment.
  • BST has a Altman-Z score of 3.02. This is amongst the best in the industry. BST outperforms 91.18% of its industry peers.
  • A Debt/Equity ratio of 0.05 indicates that BST is not too dependend on debt financing.
  • BST's Debt to Equity ratio of 0.05 is amongst the best of the industry. BST outperforms 86.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 3.02
ROIC/WACC1.65
WACC7.17%
BST.DE Yearly LT Debt VS Equity VS FCFBST.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 1.46 indicates that BST should not have too much problems paying its short term obligations.
  • The Current ratio of BST (1.46) is better than 82.35% of its industry peers.
  • A Quick Ratio of 1.07 indicates that BST should not have too much problems paying its short term obligations.
  • The Quick ratio of BST (1.07) is better than 69.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 1.07
BST.DE Yearly Current Assets VS Current LiabilitesBST.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2

3. Growth

3.1 Past

  • BST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.71%.
  • BST shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.14% yearly.
  • Looking at the last year, BST shows a decrease in Revenue. The Revenue has decreased by -1.26% in the last year.
  • BST shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.95% yearly.
EPS 1Y (TTM)-11.71%
EPS 3Y1.14%
EPS 5YN/A
EPS Q2Q%-7.69%
Revenue 1Y (TTM)-1.26%
Revenue growth 3Y6.45%
Revenue growth 5Y6.95%
Sales Q2Q%12.82%

3.2 Future

  • BST is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.39% yearly.
  • The Revenue is expected to grow by 0.99% on average over the next years.
EPS Next Y-6.59%
EPS Next 2Y1.73%
EPS Next 3Y-0.39%
EPS Next 5YN/A
Revenue Next Year3.46%
Revenue Next 2Y3.17%
Revenue Next 3Y3.26%
Revenue Next 5Y0.99%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BST.DE Yearly Revenue VS EstimatesBST.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M
BST.DE Yearly EPS VS EstimatesBST.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 10.36, the valuation of BST can be described as very reasonable.
  • Based on the Price/Earnings ratio, BST is valued a bit cheaper than the industry average as 67.65% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of BST to the average of the S&P500 Index (27.92), we can say BST is valued rather cheaply.
  • BST is valuated reasonably with a Price/Forward Earnings ratio of 8.30.
  • Based on the Price/Forward Earnings ratio, BST is valued a bit cheaper than the industry average as 69.12% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.78, BST is valued rather cheaply.
Industry RankSector Rank
PE 10.36
Fwd PE 8.3
BST.DE Price Earnings VS Forward Price EarningsBST.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as BST.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.76
BST.DE Per share dataBST.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • BST has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.73%
EPS Next 3Y-0.39%

7

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.65%, BST is a good candidate for dividend investing.
  • In the last 3 months the price of BST has falen by -21.47%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • BST's Dividend Yield is a higher than the industry average which is at 2.27.
  • Compared to an average S&P500 Dividend Yield of 1.81, BST pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.65%

5.2 History

  • On average, the dividend of BST grows each year by 156.54%, which is quite nice.
Dividend Growth(5Y)156.54%
Div Incr Years1
Div Non Decr Years1
BST.DE Yearly Dividends per shareBST.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

  • 50.46% of the earnings are spent on dividend by BST. This is a bit on the high side, but may be sustainable.
  • The Dividend Rate of BST has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP50.46%
EPS Next 2Y1.73%
EPS Next 3Y-0.39%
BST.DE Yearly Income VS Free CF VS DividendBST.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M 15M
BST.DE Dividend Payout.BST.DE Dividend Payout, showing the Payout Ratio.BST.DE Dividend Payout.PayoutRetained Earnings

BASTEI LUBBE AG

FRA:BST (2/6/2026, 7:00:00 PM)

7.46

-0.28 (-3.62%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-05
Earnings (Next)07-13
Inst Owners5.44%
Inst Owner ChangeN/A
Ins Owners39.08%
Ins Owner ChangeN/A
Market Cap99.22M
Revenue(TTM)114.43M
Net Income(TTM)9.42M
Analysts87.5
Price Target13.21 (77.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.65%
Yearly Dividend0.3
Dividend Growth(5Y)156.54%
DP50.46%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.36
Fwd PE 8.3
P/S 0.87
P/FCF N/A
P/OCF N/A
P/B 1.46
P/tB 1.62
EV/EBITDA 6.76
EPS(TTM)0.72
EY9.65%
EPS(NY)0.9
Fwd EY12.05%
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.47
OCFYN/A
SpS8.6
BVpS5.1
TBVpS4.6
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.09
Profitability
Industry RankSector Rank
ROA 7.78%
ROE 13.88%
ROCE 17.42%
ROIC 11.8%
ROICexc 12.87%
ROICexgc 14.25%
OM 11.41%
PM (TTM) 8.23%
GM 51.6%
FCFM N/A
ROA(3y)7.31%
ROA(5y)8.15%
ROE(3y)12.63%
ROE(5y)15.01%
ROIC(3y)11.74%
ROIC(5y)11.8%
ROICexc(3y)15.22%
ROICexc(5y)15.52%
ROICexgc(3y)17.65%
ROICexgc(5y)18.64%
ROCE(3y)17.34%
ROCE(5y)17.43%
ROICexgc growth 3Y-3.07%
ROICexgc growth 5Y16.83%
ROICexc growth 3Y1.69%
ROICexc growth 5Y15.18%
OM growth 3Y5.11%
OM growth 5Y25.16%
PM growth 3Y-4.99%
PM growth 5YN/A
GM growth 3Y1.19%
GM growth 5Y3.74%
F-Score3
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA 0.23
Cap/Depr 73.65%
Cap/Sales 1.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.46
Quick Ratio 1.07
Altman-Z 3.02
F-Score3
WACC7.17%
ROIC/WACC1.65
Cap/Depr(3y)46.32%
Cap/Depr(5y)34.22%
Cap/Sales(3y)1.19%
Cap/Sales(5y)0.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.71%
EPS 3Y1.14%
EPS 5YN/A
EPS Q2Q%-7.69%
EPS Next Y-6.59%
EPS Next 2Y1.73%
EPS Next 3Y-0.39%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.26%
Revenue growth 3Y6.45%
Revenue growth 5Y6.95%
Sales Q2Q%12.82%
Revenue Next Year3.46%
Revenue Next 2Y3.17%
Revenue Next 3Y3.26%
Revenue Next 5Y0.99%
EBIT growth 1Y-16.35%
EBIT growth 3Y11.89%
EBIT growth 5Y33.86%
EBIT Next Year5.91%
EBIT Next 3Y4.88%
EBIT Next 5YN/A
FCF growth 1Y-228.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-193.21%
OCF growth 3YN/A
OCF growth 5YN/A

BASTEI LUBBE AG / BST.DE FAQ

What is the ChartMill fundamental rating of BASTEI LUBBE AG (BST.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to BST.DE.


What is the valuation status of BASTEI LUBBE AG (BST.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to BASTEI LUBBE AG (BST.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for BASTEI LUBBE AG?

BASTEI LUBBE AG (BST.DE) has a profitability rating of 7 / 10.


What is the valuation of BASTEI LUBBE AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BASTEI LUBBE AG (BST.DE) is 10.36 and the Price/Book (PB) ratio is 1.46.


How financially healthy is BASTEI LUBBE AG?

The financial health rating of BASTEI LUBBE AG (BST.DE) is 6 / 10.